NewAmsterdam Pharma (NAMS) Earnings Analysis
NewAmsterdam Pharma (NAMS) has no confirmed upcoming earnings date. In its last reported quarter (2026-05-07) NAMS beat analyst consensus (+13% EPS surprise). Trailing P/E -17.51.
Last updated 2026-07-23 · Source: company filings + earnings calendar; consensus from sell-side analyst grades
When does NAMS next report earnings?
No confirmed upcoming earnings date is currently scheduled for NAMS. This page updates as the calendar is published.
NAMS last-quarter earnings result
| Last reported quarter | 2026-05-07 |
|---|---|
| Result vs consensus | Beat (+13% EPS surprise) |
NAMS consensus estimates and analyst view
Consensus estimates, 8-quarter history and analyst targets are in the SniperIQ app. Create a free account to see them.
Related research pages
More on NAMS
Frequently asked questions
When does NAMS next report earnings?
NAMS has no confirmed upcoming earnings date right now; this page updates as the calendar is published.
Did NAMS beat earnings last quarter?
In its 2026-05-07 report, NAMS beat analyst consensus (+13% EPS surprise).
Where can I see NAMS analyst estimates and price targets?
Consensus estimates, 8-quarter history and analyst targets for NAMS are in the SniperIQ app: https://app.sniperiq.ai/register